To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CAPGTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
625 representative clones for gene CAPG back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG762391 melanotic melanoma, high MDR (cell line), skin .a 1 to 758 1 to 758       758/758
(100 %)
4 diff
(99.5 %id)
BG763493 melanotic melanoma, high MDR (cell line), skin .a 1 to 841 1 to 847       847/909
(93 %)
21 diff
(97.7 %id)
BG765240 melanotic melanoma, high MDR (cell line), skin .a 1 to 622 1 to 622   tiling clone,   622/625
(99 %)
2 diff
(99.7 %id)
BG769824 melanotic melanoma, high MDR (cell line), skin .a 1 to 684 1 to 691       691/1033
(66 %)
30 diff
(97.1 %id)
CD702439 normal nasopharynx .a 3 to 452 14 to 462       449/462
(97 %)
7 diff
(98.5 %id)
BF692255 melanotic melanoma, high MDR, skin .a 6 to 694 1 to 676       676/876
(77 %)
27 diff
(97.0 %id)
BF690926 melanotic melanoma, high MDR, skin .a 21 to 597 1 to 589       589/892
(66 %)
38 diff
(95.8 %id)
BP301785   .a 21 to 601 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP301874   .a 21 to 597 1 to 577       577/582
(99 %)
3 diff
(99.5 %id)
BP303632   .a 24 to 597 1 to 574       574/582
(98 %)
1 diff
(99.9 %id)
BF689869 melanotic melanoma, high MDR (cell line), skin .a 26 to 463 1 to 457   fully sequenced,   457/457
(100 %)
19 diff
(95.9 %id)
BG475204 melanotic melanoma, skin .a 30 to 629 1 to 600       600/600
(100 %)
6 diff
(99.0 %id)
BG770703 melanotic melanoma, high MDR (cell line), skin .a 30 to 801 1 to 773       773/773
(100 %)
9 diff
(98.9 %id)
BG764382 melanotic melanoma, high MDR (cell line), skin .a 30 to 855 1 to 821       821/821
(100 %)
25 diff
(97.0 %id)
BG764115 melanotic melanoma, high MDR (cell line), skin .a 30 to 758 1 to 726       726/729
(99 %)
8 diff
(99.0 %id)
BG765264 melanotic melanoma, high MDR (cell line), skin .a 30 to 818 1 to 795       795/796
(99 %)
15 diff
(98.2 %id)
BG768354 melanotic melanoma, high MDR (cell line), skin .a 30 to 821 1 to 799       799/799
(100 %)
18 diff
(97.8 %id)
BG768341 melanotic melanoma, high MDR (cell line), skin .a 30 to 791 1 to 759       759/762
(99 %)
10 diff
(98.7 %id)
BG769632 melanotic melanoma, high MDR (cell line), skin .a 30 to 745 1 to 721       721/1052
(68 %)
10 diff
(99.1 %id)
BG764550 melanotic melanoma, high MDR (cell line), skin .a 32 to 727 1 to 694       694/760
(91 %)
9 diff
(98.9 %id)
BG770366 melanotic melanoma, high MDR (cell line), skin .a 32 to 755 1 to 738       738/950
(77 %)
31 diff
(96.8 %id)
BQ217642 embryonal carcinoma, cell line, testis .a 34 to 755 1 to 728       728/877
(83 %)
8 diff
(99.1 %id)
BG768960 melanotic melanoma, high MDR (cell line), skin .a 35 to 672 1 to 638       638/640
(99 %)
6 diff
(99.1 %id)
BF689420 melanotic melanoma, high MDR (cell line), skin .a 37 to 469 1 to 433       433/434
(99 %)
2 diff
(99.6 %id)
BG761871 melanotic melanoma, high MDR (cell line), skin .a 37 to 715 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
BG765447 melanotic melanoma, high MDR (cell line), skin .a 37 to 666 1 to 663       485/663
(73 %)
23 diff
(96.6 %id)
BG766333 melanotic melanoma, high MDR (cell line), skin .a 37 to 840 1 to 805       805/805
(100 %)
7 diff
(99.2 %id)
BG767065 melanotic melanoma, high MDR (cell line), skin .a 37 to 902 1 to 870       867/871
(99 %)
22 diff
(97.5 %id)
BG768110 melanotic melanoma, high MDR (cell line), skin .a 37 to 691 1 to 653       653/653
(100 %)
3 diff
(99.6 %id)
AV683204 hepatocellular carcinoma .a 38 to 423 1 to 386       386/394
(97 %)
7 diff
(98.3 %id)
BG761525 melanotic melanoma, high MDR (cell line), skin .a 40 to 838 1 to 798       796/799
(99 %)
15 diff
(98.2 %id)
BG765431 melanotic melanoma, high MDR (cell line), skin .a 42 to 532 1 to 490       490/491
(99 %)
2 diff
(99.6 %id)
BG761214 melanotic melanoma, high MDR (cell line), skin .a 44 to 832 1 to 795       795/839
(94 %)
28 diff
(96.7 %id)
BG760919 melanotic melanoma, high MDR (cell line), skin .a 45 to 811 1 to 768       768/768
(100 %)
4 diff
(99.5 %id)
BG762365 melanotic melanoma, high MDR (cell line), skin .a 45 to 838 1 to 799       799/909
(87 %)
25 diff
(97.3 %id)
BG765604 melanotic melanoma, high MDR (cell line), skin .a 45 to 727 1 to 682       682/748
(91 %)
20 diff
(97.4 %id)
BG765882 melanotic melanoma, high MDR (cell line), skin .a 45 to 824 1 to 784       784/1121
(69 %)
23 diff
(98.0 %id)
BG766880 melanotic melanoma, high MDR (cell line), skin .a 45 to 796 1 to 755       755/755
(100 %)
6 diff
(99.3 %id)
BG767844 melanotic melanoma, high MDR (cell line), skin .a 45 to 747 1 to 707       707/707
(100 %)
12 diff
(98.4 %id)
BG767691 melanotic melanoma, high MDR (cell line), skin .a 45 to 778 1 to 729       729/729
(100 %)
7 diff
(99.1 %id)
BG770355 melanotic melanoma, high MDR (cell line), skin .a 45 to 773 1 to 744       739/940
(78 %)
24 diff
(97.5 %id)
BG769309 melanotic melanoma, high MDR (cell line), skin .a 45 to 814 1 to 783       781/787
(99 %)
25 diff
(96.9 %id)
BG769146 melanotic melanoma, high MDR (cell line), skin .a 45 to 876 1 to 835       835/835
(100 %)
21 diff
(97.5 %id)
BG769565 melanotic melanoma, high MDR (cell line), skin .a 45 to 880 1 to 830       830/840
(98 %)
18 diff
(97.9 %id)
BG764031 melanotic melanoma, high MDR (cell line), skin .a 46 to 795 1 to 747       747/747
(100 %)
4 diff
(99.5 %id)
BF025728 melanotic melanoma, skin .a 50 to 824 1 to 765       765/791
(96 %)
22 diff
(97.3 %id)
BE274145 melanotic melanoma, skin .a 51 to 740 1 to 684       684/688
(99 %)
9 diff
(98.7 %id)
BE729786 melanotic melanoma, skin .a 51 to 879 1 to 816       819/818
(100 %)
32 diff
(96.1 %id)
BE727766 melanotic melanoma, skin .a 51 to 779 1 to 724       724/726
(99 %)
6 diff
(99.2 %id)
BE385262 melanotic melanoma, skin .a 52 to 654 1 to 604       604/605
(99 %)
4 diff
(99.4 %id)
BG762660 melanotic melanoma, high MDR (cell line), skin .a 52 to 755 1 to 704       704/804
(87 %)
7 diff
(99.2 %id)
BG761992 melanotic melanoma, high MDR (cell line), skin .a 54 to 795 1 to 737       737/738
(99 %)
8 diff
(99.0 %id)
BG766834 melanotic melanoma, high MDR (cell line), skin .a 54 to 936 1 to 886       886/889
(99 %)
21 diff
(97.7 %id)
BG763994 melanotic melanoma, high MDR (cell line), skin .a 56 to 872 1 to 811   tiling clone,   811/813
(99 %)
15 diff
(98.2 %id)
BG764077 melanotic melanoma, high MDR (cell line), skin .a 56 to 842 1 to 786       786/851
(92 %)
13 diff
(98.5 %id)
BG769574 melanotic melanoma, high MDR (cell line), skin .a 56 to 714 1 to 657       657/657
(100 %)
3 diff
(99.6 %id)
BQ431787 melanotic melanoma, skin .a 56 to 797 1 to 752       749/954
(78 %)
15 diff
(98.5 %id)
BF690096 melanotic melanoma, high MDR (cell line), skin .a 433 to 1234 812 to 9   tiling clone, fully sequenced,   804/812
(99 %)
7 diff
(99.2 %id)
BF690369 melanotic melanoma, high MDR (cell line), skin .a 499 to 1218 725 to 2   tiling clone,   724/1033
(70 %)
17 diff
(98.4 %id)
CN261517 embryonic stem cells, DMSO-treated H9 cellline .b 1 to 345 1 to 345       345/345
(100 %)
4 diff
(98.9 %id)
AU099216   .b 2 to 301 1 to 300   tiling clone,   300/300
(100 %)
2 diff
(99.4 %id)
BP252996 Kidney .b 2 to 585 1 to 584       584/584
(100 %)
4 diff
(99.4 %id)
CB137524 Liver .b 3 to 514 1 to 511       511/511
(100 %)
10 diff
(98.1 %id)
AI209005   .b 21 to 515 1 to 494     Submitted on the opposite strand 494/494
(100 %)
5 diff
(99.0 %id)
AW119091 pooled .b 21 to 493 1 to 473     Submitted on the opposite strand 473/473
(100 %)
2 diff
(99.6 %id)
CX166028 human embryonic stem cells differentiated toan early endodermal cell type .b 28 to 584 1 to 557       557/557
(100 %)
0 diff
(100 %id)
CB140435 Liver .b 29 to 596 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
BQ941881 epidermoid carcinoma, cell line, lung .b 30 to 855 1 to 833       833/883
(94 %)
25 diff
(97.2 %id)
CB124234 Liver .b 31 to 526 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
CB141658 Liver .b 31 to 454 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
CB149314 Liver .b 31 to 617 1 to 586       586/586
(100 %)
4 diff
(99.4 %id)
CB141352 Liver .b 32 to 614 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
AL578339 placenta .b 33 to 652 1 to 620   fully sequenced,   620/620
(100 %)
7 diff
(98.9 %id)
CR607458 HeLa cells Cot 25-normalized .b 34 to 1217 1 to 1183 exact     1184/1183
(100 %)
6 diff
(99.5 %id)
BQ670379 epidermoid carcinoma, cell line, salivary gland .b 34 to 864 13 to 849       835/895
(93 %)
39 diff
(95.7 %id)
BQ672151 epidermoid carcinoma, cell line, salivary gland .b 44 to 950 26 to 937       912/940
(97 %)
31 diff
(96.8 %id)
BQ671169 epidermoid carcinoma, cell line, salivary gland .b 45 to 863 1 to 826       826/908
(90 %)
14 diff
(98.5 %id)
BQ675222 epidermoid carcinoma, cell line, salivary gland .b 45 to 857 1 to 819       819/965
(84 %)
23 diff
(97.7 %id)
AW270152 pooled .b 46 to 519 1 to 474     Submitted on the opposite strand 474/474
(100 %)
0 diff
(100 %id)
CB149053 Liver .b 48 to 541 1 to 494       494/494
(100 %)
4 diff
(99.2 %id)
BI601767 brain, hypothalamus .b 50 to 588 1 to 539       539/695
(77 %)
11 diff
(98.5 %id)
CN261522 embryonic stem cells, cell lines H1, H7, andH9 .b 52 to 598 25 to 572       548/572
(95 %)
7 diff
(98.8 %id)
TI_45211325   .b 55 to 588 118 to 651       534/807
(66 %)
10 diff
(98.8 %id)
CB111717 Liver .b 55 to 614 1 to 560       560/560
(100 %)
2 diff
(99.7 %id)
BP382091 adipose tissue .b 57 to 680 1 to 624       624/626
(99 %)
3 diff
(99.6 %id)
BM906273 ovary (pool of 3) .b 57 to 772 7 to 728       722/1168
(61 %)
19 diff
(98.4 %id)
BP305880   .b 57 to 621 1 to 565       565/582
(97 %)
2 diff
(99.7 %id)
AK313898 amygdala .b 58 to 1152 1 to 1095 D286N     1095/1095
(100 %)
1 diff
(100.0 %id)
CB105722 Liver .b 58 to 574 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
CB105737 Liver .b 58 to 540 1 to 483       483/483
(100 %)
1 diff
(99.8 %id)
CB105762 Liver .b 58 to 612 1 to 554       554/554
(100 %)
3 diff
(99.5 %id)
CB124941 Liver .b 58 to 604 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
DA871424 Prostate .b 58 to 592 2 to 536   capped   535/535
(100 %)
2 diff
(99.7 %id)
DA161417 amygdala .b 59 to 631 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF381826 brain, primitive neuroectoderm .b 59 to 727 1 to 658       658/859
(76 %)
13 diff
(98.5 %id)
BF382626 brain, primitive neuroectoderm .b 59 to 728 1 to 685       683/690
(98 %)
42 diff
(94.0 %id)
BF540900 hypernephroma, Kidney .b 59 to 692 1 to 627       627/631
(99 %)
12 diff
(98.1 %id)
BG540125 lung .b 59 to 796 1 to 777       777/781
(99 %)
59 diff
(92.5 %id)
CB105712 Liver .b 59 to 608 1 to 549       549/549
(100 %)
3 diff
(99.5 %id)
CB105728 Liver .b 59 to 513 1 to 454       454/454
(100 %)
7 diff
(98.5 %id)
CB105774 Liver .b 59 to 607 1 to 548       548/548
(100 %)
3 diff
(99.5 %id)
CB105798 Liver .b 59 to 619 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
CB127920 cervix, Uterine .b 60 to 604 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
BP255750 Kidney .b 60 to 638 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
BF973294 leiomyosarcoma cell line, uterus .b 60 to 838 1 to 776       776/881
(88 %)
18 diff
(98.0 %id)
BG338650 leiomyosarcoma cell line, uterus .b 60 to 747 1 to 693       693/1186
(58 %)
10 diff
(99.2 %id)
BM020772 astrocytoma grade IV, cell line, brain .b 60 to 746 1 to 698       698/698
(100 %)
22 diff
(96.9 %id)
CB140918 Liver .b 60 to 574 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BP295628   .b 60 to 641 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP298769   .b 60 to 641 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP303136   .b 60 to 638 1 to 578       578/582
(99 %)
2 diff
(99.7 %id)
BP332126 renal proximal tubule .b 60 to 645 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
BM750893 Ascites, stomach .b 60 to 614 1 to 555       555/555
(100 %)
3 diff
(99.5 %id)
DA421471 cervix .b 61 to 644 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DA575752   .b 61 to 613 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BG339550 leiomyosarcoma cell line, uterus .b 61 to 749 2 to 684       683/684
(99 %)
15 diff
(97.9 %id)
BM017535 astrocytoma grade IV, cell line, brain .b 61 to 684 2 to 624       623/624
(99 %)
21 diff
(96.7 %id)
BM548969 astrocytoma grade IV, cell line, brain .b 61 to 760 1 to 701       701/1109
(63 %)
16 diff
(98.6 %id)
TI_59387847   .b 61 to 746 98 to 794       697/697
(100 %)
21 diff
(97.0 %id)
TI_59388037   .b 61 to 684 107 to 729       623/623
(100 %)
17 diff
(97.3 %id)
BM908864 astrocytoma grade IV, cell line, brain .b 62 to 741 1 to 680       680/1122
(60 %)
16 diff
(98.6 %id)
DB490653 hypothalamus .b 63 to 475 1 to 412       412/412
(100 %)
1 diff
(99.8 %id)
AW328245 cervix .b 63 to 598 1 to 536       536/536
(100 %)
2 diff
(99.7 %id)
BI116272 lung, small cell carcinoma .b 66 to 984 1 to 918       917/920
(99 %)
40 diff
(95.7 %id)
CN261520 embryonic stem cells, cell lines H1, H7, andH9 .b 67 to 573 1 to 507       507/507
(100 %)
3 diff
(99.5 %id)
BE537432 cervix .b 67 to 782 1 to 736       684/978
(69 %)
49 diff
(95.0 %id)
DA378948 thalamus .b 68 to 614 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BU527388 epidermoid carcinoma, cell line, lung .b 68 to 921 1 to 857       857/858
(99 %)
12 diff
(98.7 %id)
BU528678 epidermoid carcinoma, cell line, lung .b 68 to 595 1 to 534       534/795
(67 %)
12 diff
(98.5 %id)
BF211028 bone marrow, from chronic myelogenous leukemia .b 69 to 677 1 to 611       611/611
(100 %)
14 diff
(97.8 %id)
BG169631 hypernephroma, cell line, Kidney .b 69 to 819 1 to 744       744/859
(86 %)
17 diff
(98.1 %id)
BM914036 astrocytoma grade IV, cell line, brain .b 69 to 769 1 to 707       707/1138
(62 %)
25 diff
(97.9 %id)
BQ894735 eye, normal pigmented retinal epithelium .b 69 to 558 1 to 492       492/1477
(33 %)
17 diff
(98.9 %id)
CN261519 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 70 to 767 1 to 699       699/699
(100 %)
3 diff
(99.6 %id)
BI088728 cervix .b 70 to 818 1 to 750       750/751
(99 %)
20 diff
(97.4 %id)
CB215081 normal endometrium, late proliferativephase, cycle day 13, uterus .b 70 to 697 1 to 628       628/629
(99 %)
1 diff
(99.9 %id)
DR158305 human embryonic stem cells differentiated toan early endodermal cell type .b 72 to 811 1 to 740       740/740
(100 %)
1 diff
(99.9 %id)
CD697267 normal nasopharynx .b 73 to 628 1 to 556       556/556
(100 %)
0 diff
(100 %id)
DA574265   .b 73 to 617 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
TI_57228377   .b 73 to 982 46 to 965       920/927
(99 %)
19 diff
(98.0 %id)
BM541252 leiomyosarcoma, uterus .b 74 to 1082 1 to 1010       1010/1057
(95 %)
20 diff
(98.2 %id)
BQ268112 insulinoma, Pancreas .b 74 to 495 8 to 429       422/429
(98 %)
6 diff
(98.7 %id)
BU501325 eye, normal pigmented retinal epithelium .b 74 to 865 1 to 793       793/862
(91 %)
5 diff
(99.5 %id)
CX163793 human embryonic stem cells differentiated toan early endodermal cell type .b 74 to 860 1 to 787       787/787
(100 %)
0 diff
(100 %id)
TI_57231075   .b 74 to 556 55 to 537       483/486
(99 %)
2 diff
(99.6 %id)
BG822601 adenocarcinoma cell line, colon .b 75 to 814 2 to 747       746/749
(99 %)
14 diff
(98.2 %id)
BI870122 adenocarcinoma, cell line, Liver .b 76 to 556 1 to 481       481/484
(99 %)
2 diff
(99.6 %id)
BM913604 astrocytoma grade IV, cell line, brain .b 76 to 620 1 to 547       547/1094
(50 %)
3 diff
(99.8 %id)
BQ961175 large cell carcinoma, lung .b 76 to 849 1 to 787       787/978
(80 %)
17 diff
(98.3 %id)
CX757509 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 76 to 802 1 to 725     Submitted on the opposite strand 725/728
(99 %)
17 diff
(97.7 %id)
CD612765   .b 78 to 667 2 to 593       592/599
(98 %)
12 diff
(98.0 %id)
CD612766   .b 78 to 667 598 to 6       593/615
(96 %)
15 diff
(97.6 %id)
BU187926 leiomyosarcoma, uterus .b 78 to 954 12 to 895       884/902
(98 %)
18 diff
(98.1 %id)
CB141295 Liver .b 78 to 590 1 to 513       513/513
(100 %)
1 diff
(99.9 %id)
BU527798 epidermoid carcinoma, cell line, lung .b 79 to 991 1 to 922       922/979
(94 %)
36 diff
(96.4 %id)
BM470864 leiomyosarcoma, uterus .b 80 to 973 1 to 901       901/1043
(86 %)
15 diff
(98.6 %id)
CB993818 placenta, pre-eclamptic placenta .b 80 to 849 28 to 802       775/808
(95 %)
11 diff
(98.7 %id)
BE786041 large cell carcinoma, lung .b 82 to 777 1 to 703       703/913
(76 %)
7 diff
(99.3 %id)
BG253010 adenocarcinoma, cell line, Liver .b 82 to 748 1 to 668       668/669
(99 %)
7 diff
(99.0 %id)
BG675961 skin, squamous cell carcinoma .b 84 to 866 2 to 793       792/922
(85 %)
16 diff
(98.3 %id)
BM909826 astrocytoma grade IV, cell line, brain .b 86 to 865 33 to 815       783/1081
(72 %)
21 diff
(98.1 %id)
BE730632 choriocarcinoma, placenta .b 87 to 826 1 to 731       731/855
(85 %)
11 diff
(98.8 %id)
BG767574 melanotic melanoma, high MDR (cell line), skin .b 87 to 988 1 to 902       900/902
(99 %)
29 diff
(96.8 %id)
TI_57145960   .b 88 to 903 103 to 917       815/917
(88 %)
11 diff
(98.9 %id)
R70307 breast .b 89 to 391 1 to 303       303/303
(100 %)
2 diff
(99.4 %id)
BQ921976 epidermoid carcinoma, cell line, lung .b 89 to 998 1 to 910       910/955
(95 %)
17 diff
(98.3 %id)
BX091580 breast .b 90 to 854 1 to 765       765/765
(100 %)
0 diff
(100 %id)
CR603008 HeLa cells Cot 25-normalized .b 90 to 1249 1 to 1160 exact     1160/1160
(100 %)
0 diff
(100 %id)
CR613943 Placenta Cot 25-normalized .b 90 to 1258 1 to 1169 exact     1169/1169
(100 %)
0 diff
(100 %id)
CR615009 Placenta Cot 25-normalized .b 90 to 1263 1 to 1174 exact tiling clone,   1174/1174
(100 %)
0 diff
(100 %id)
AL545440 placenta, Placenta Cot 25-normalized .b 90 to 652 1 to 561   fully sequenced,   561/561
(100 %)
2 diff
(99.7 %id)
AL549359 placenta, Placenta Cot 25-normalized .b 90 to 799 1 to 719   fully sequenced,   719/719
(100 %)
18 diff
(97.5 %id)
AL555218 placenta .b 90 to 652 1 to 563   fully sequenced,   563/563
(100 %)
3 diff
(99.5 %id)
BI912594 leukocyte .b 91 to 898 32 to 843       814/843
(96 %)
11 diff
(98.7 %id)
TI_57247501   .b 91 to 898 32 to 843       814/843
(96 %)
11 diff
(98.7 %id)
BE872249 adenocarcinoma, colon .b 92 to 819 1 to 725       725/727
(99 %)
15 diff
(98.0 %id)
BQ933664 epidermoid carcinoma, cell line, lung .b 92 to 976 1 to 889       889/956
(92 %)
24 diff
(97.5 %id)
BQ228785 large cell carcinoma, lung .b 93 to 998 5 to 909       909/927
(98 %)
7 diff
(99.3 %id)
BG482210 choriocarcinoma, placenta .b 94 to 843 1 to 748       748/748
(100 %)
3 diff
(99.6 %id)
BG760999 melanotic melanoma, high MDR (cell line), skin .b 95 to 846 1 to 753       753/754
(99 %)
6 diff
(99.3 %id)
BM464360 leiomyosarcoma, uterus .b 95 to 1097 1 to 1001       1001/1078
(92 %)
18 diff
(98.4 %id)
BG333202 large cell carcinoma, lung .b 96 to 948 1 to 847       847/849
(99 %)
19 diff
(97.8 %id)
BI759137 pooled colon, kidney, stomach .b 96 to 903 1 to 807       807/807
(100 %)
1 diff
(99.9 %id)
BQ879019 ductal carcinoma, cell line, Pancreas .b 97 to 950 1 to 861       861/862
(99 %)
12 diff
(98.7 %id)
BQ691949 ductal carcinoma, cell line, Pancreas .b 97 to 944 1 to 856       856/860
(99 %)
19 diff
(97.8 %id)
BQ691419 ductal carcinoma, cell line, Pancreas .b 97 to 998 1 to 905       905/940
(96 %)
21 diff
(97.8 %id)
AA463764 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 108 to 207 1 to 100       100/100
(100 %)
6 diff
(94.0 %id)
BG761855 melanotic melanoma, high MDR (cell line), skin .b 112 to 783 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
BG761084 melanotic melanoma, high MDR (cell line), skin .b 115 to 816 1 to 704       704/704
(100 %)
6 diff
(99.2 %id)
BG764528 melanotic melanoma, high MDR (cell line), skin .b 115 to 916 1 to 807       807/815
(99 %)
12 diff
(98.6 %id)
BG761738 melanotic melanoma, high MDR (cell line), skin .b 123 to 821 1 to 703       703/703
(100 %)
7 diff
(99.1 %id)
BG481717 choriocarcinoma, placenta .b 127 to 864 1 to 740       740/906
(81 %)
15 diff
(98.4 %id)
BG754534 B-cells, primary B-cells from tonsils (cell line) .b 133 to 806 1 to 673       673/676
(99 %)
8 diff
(98.9 %id)
BU156879 melanotic melanoma, cell line, skin .b 149 to 998 1 to 852       852/917
(92 %)
13 diff
(98.6 %id)
BQ676734 melanotic melanoma, cell line, skin .b 149 to 1002 1 to 864       864/961
(89 %)
14 diff
(98.6 %id)
BQ677708 melanotic melanoma, cell line, skin .b 149 to 871 1 to 731       731/990
(73 %)
20 diff
(98.0 %id)
CR977474 T-Lymphocytes .b 162 to 866 1 to 707       707/707
(100 %)
3 diff
(99.6 %id)
CR997483 T-Lymphocytes .b 162 to 865 1 to 704       704/707
(99 %)
3 diff
(99.6 %id)
BG767700 melanotic melanoma, high MDR (cell line), skin .b 189 to 821 1 to 630       630/631
(99 %)
4 diff
(99.4 %id)
BG762707 melanotic melanoma, high MDR (cell line), skin .b 213 to 990 1 to 777       777/777
(100 %)
5 diff
(99.4 %id)
BF975581 B-cells, primary B-cells from tonsils (cell line) .b 221 to 998 1 to 796       705/804
(87 %)
25 diff
(96.9 %id)
BG758346 B-cells, primary B-cells from tonsils (cell line) .b 221 to 1159 1 to 932       932/1015
(91 %)
19 diff
(98.2 %id)
BF341583 brain, glioblastoma with EGFR amplification .b 249 to 975 1 to 727       725/727
(99 %)
9 diff
(98.8 %id)
BM924106 pooled colon, kidney, stomach .b 263 to 966 15 to 718       704/1098
(64 %)
17 diff
(98.5 %id)
BE877609 large cell carcinoma, undifferentiated, lung .b 279 to 998 1 to 716       716/794
(90 %)
6 diff
(99.3 %id)
TI_59388365   .b 298 to 998 101 to 813       713/732
(97 %)
27 diff
(96.4 %id)
BG422166 Kidney, renal cell adenocarcinoma .b 304 to 990 1 to 688       688/688
(100 %)
4 diff
(99.5 %id)
BU174130 melanotic melanoma, cell line, skin .b 336 to 1033 1 to 702       702/918
(76 %)
17 diff
(98.2 %id)
BU839338 melanotic melanoma, cell line, skin .b 336 to 993 1 to 658       658/930
(70 %)
2 diff
(99.8 %id)
BI090364 cervix .b 340 to 1034 1 to 694       694/694
(100 %)
2 diff
(99.8 %id)
BG117914 adenocarcinoma, cell line, Liver .b 371 to 913 1 to 541       541/541
(100 %)
2 diff
(99.7 %id)
BG764145 melanotic melanoma, high MDR (cell line), skin .b 385 to 999 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BE882068 leiomyosarcoma, uterus .b 413 to 1079 1 to 661       661/909
(72 %)
11 diff
(98.8 %id)
BE882169 leiomyosarcoma, uterus .b 414 to 1019 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
AL571161 placenta, Placenta Cot 25-normalized .b 591 to 1263 674 to 1   fully sequenced,   674/674
(100 %)
15 diff
(97.8 %id)
AL577768 placenta .b 591 to 1190 659 to 60   fully sequenced,   600/604
(99 %)
3 diff
(99.6 %id)
AL555970 placenta .b 591 to 1217 627 to 1   fully sequenced,   627/627
(100 %)
9 diff
(98.6 %id)
BQ267859 insulinoma, Pancreas .b 673 to 1286 616 to 3   tiling clone,   614/616
(99 %)
1 diff
(99.9 %id)
FN107025 breast carcinoma .b 696 to 791 1 to 96       96/96
(100 %)
0 diff
(100 %id)
AW001139 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 709 to 1273 569 to 6       564/569
(99 %)
15 diff
(97.4 %id)
AI376559 pooled .b 710 to 1278 565 to 1       565/567
(99 %)
18 diff
(96.9 %id)
FN104983 breast carcinoma .b 714 to 810 93 to 1     Submitted on the opposite strand 93/93
(100 %)
4 diff
(95.7 %id)
AA622024 colon, colon tumor RER+ .b 715 to 1273 564 to 6       559/564
(99 %)
4 diff
(99.3 %id)
AI433080 lymph node, lymphoma, follicular mixed small and largecell .b 715 to 1277 576 to 14   AAA   563/563
(100 %)
4 diff
(99.3 %id)
AI805646 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 715 to 1278 564 to 3       562/564
(99 %)
14 diff
(97.6 %id)
AA570328 colon, colon tumor RER+ .b 719 to 1272 556 to 1       556/568
(97 %)
6 diff
(99.0 %id)
AI683021 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 721 to 1272 576 to 25   AAA   552/561
(98 %)
13 diff
(97.7 %id)
FN091610 breast carcinoma .b 744 to 794 1 to 51       51/52
(98 %)
1 diff
(98.1 %id)
FN063323 breast carcinoma .b 750 to 824 1 to 75       75/75
(100 %)
1 diff
(98.7 %id)
AL573622 placenta, Placenta Cot 25-normalized .b 769 to 1258 488 to 1   fully sequenced,   488/488
(100 %)
13 diff
(97.4 %id)
R70257 breast .b 769 to 1254 494 to 1       492/518
(94 %)
19 diff
(96.4 %id)
BF742034 bocio_tumor .b 793 to 919 1 to 127       127/127
(100 %)
0 diff
(100 %id)
AW328246 cervix .b 841 to 1272 456 to 25   AAA   432/432
(100 %)
0 diff
(100 %id)
BM546242 ovary (pool of 3) .b 864 to 1277 16 to 429   AAA   417/429
(97 %)
6 diff
(98.7 %id)
BQ883357 melanotic melanoma, cell line, skin .b 864 to 1272 12 to 420   AAA   410/420
(97 %)
7 diff
(98.4 %id)
AW798075 uterus .b 867 to 1174 313 to 6       308/313
(98 %)
2 diff
(99.4 %id)
BE939406 uterus .b 867 to 1174 313 to 6       308/313
(98 %)
2 diff
(99.4 %id)
BF985028 uterus .b 867 to 1174 313 to 6       308/313
(98 %)
2 diff
(99.4 %id)
AI862584 2 pooled tumors (clear cell type), Kidney .b 880 to 1278 405 to 7       399/405
(98 %)
0 diff
(100 %id)
BQ015816 lung, Metastatic Chondrosarcoma .b 880 to 1277 416 to 19   AAA   398/406
(98 %)
0 diff
(100 %id)
AA463702 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 898 to 1284 386 to 1       386/387
(99 %)
7 diff
(98.2 %id)
FN083124 breast carcinoma .b 900 to 988 1 to 89       89/89
(100 %)
2 diff
(97.8 %id)
FN054303 breast carcinoma .b 930 to 1020 1 to 91       91/91
(100 %)
0 diff
(100 %id)
AK130130   .c 1 to 1566 1 to 1566 exact tiling clone, available from FLJ,   1566/1566
(100 %)
0 diff
(100 %id)
BU162528 melanotic melanoma, cell line, skin .c 145 to 906 1 to 767       767/868
(88 %)
10 diff
(98.9 %id)
BU157254 melanotic melanoma, cell line, skin .c 145 to 911 1 to 779       779/966
(80 %)
14 diff
(98.6 %id)
BU163126 melanotic melanoma, cell line, skin .c 145 to 797 1 to 653       653/983
(66 %)
13 diff
(98.7 %id)
NM_001747.2   .c 145 to 1586 1 to 1442 exact RefSeq, AAA   1442/1442
(100 %)
0 diff
(100 %id)
BG766280 melanotic melanoma, high MDR (cell line), skin .c 243 to 1052 1 to 820       820/877
(93 %)
22 diff
(97.5 %id)
DB469639 hippocampus .c 291 to 749 1 to 459       459/459
(100 %)
1 diff
(99.8 %id)
BM043434 carcinoma, cell line, Prostate .c 293 to 1050 1 to 759       759/766
(99 %)
6 diff
(99.3 %id)
BM045992 carcinoma, cell line, Prostate .c 293 to 1066 1 to 776       776/836
(92 %)
8 diff
(99.1 %id)
BF692221 melanotic melanoma, high MDR, skin .c 304 to 846 3 to 567       565/1046
(54 %)
45 diff
(95.7 %id)
BE892216 melanotic melanoma, skin .c 305 to 925 11 to 630       620/630
(98 %)
9 diff
(98.6 %id)
BF978429 melanotic melanoma, high MDR, skin .c 311 to 1069 1 to 753       753/822
(91 %)
20 diff
(97.6 %id)
BM479794 embryonal carcinoma, cell line, testis .c 311 to 1291 1 to 989       989/1019
(97 %)
22 diff
(97.9 %id)
BU177539 melanotic melanoma, skin .c 312 to 1145 1 to 838       838/843
(99 %)
9 diff
(99.0 %id)
BG762409 melanotic melanoma, high MDR (cell line), skin .c 313 to 1037 1 to 726       726/862
(84 %)
15 diff
(98.3 %id)
BG764278 melanotic melanoma, high MDR (cell line), skin .c 313 to 1097 1 to 784       784/785
(99 %)
6 diff
(99.3 %id)
CR613753 Placenta Cot 25-normalized .c 314 to 1523 1 to 1210 exact     1210/1210
(100 %)
0 diff
(100 %id)
BU185668 melanotic melanoma, cell line, skin .c 322 to 1068 21 to 775       755/969
(77 %)
23 diff
(97.7 %id)
BQ680567 melanotic melanoma, cell line, skin .c 322 to 1154 7 to 841       835/857
(97 %)
14 diff
(98.4 %id)
BG764078 melanotic melanoma, high MDR (cell line), skin .c 324 to 1119 1 to 797       795/800
(99 %)
11 diff
(98.7 %id)
BU155570 melanotic melanoma, skin .c 325 to 1044 24 to 749       726/946
(76 %)
17 diff
(98.3 %id)
BQ893117 melanotic melanoma, cell line, skin .c 326 to 990 1 to 669       669/913
(73 %)
16 diff
(98.3 %id)
BU145281 melanotic melanoma, cell line, skin .c 326 to 1222 1 to 900       900/901
(99 %)
11 diff
(98.8 %id)
BQ676220 melanotic melanoma, cell line, skin .c 326 to 1068 1 to 746       746/942
(79 %)
19 diff
(98.0 %id)
BP251940 Kidney .c 328 to 910 1 to 583       583/584
(99 %)
2 diff
(99.7 %id)
BP251941 Kidney .c 328 to 908 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BG766393 melanotic melanoma, high MDR (cell line), skin .c 329 to 1048 1 to 721       721/724
(99 %)
6 diff
(99.2 %id)
BG393344 embryonal carcinoma, cell line, testis .c 330 to 1223 1 to 892       894/933
(95 %)
29 diff
(96.9 %id)
DT217566 brain .c 332 to 1009 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
BF691033 melanotic melanoma, high MDR, skin .c 332 to 910 1 to 576       576/878
(65 %)
15 diff
(98.3 %id)
BF691446 melanotic melanoma, high MDR, skin .c 332 to 1066 1 to 741       741/783
(94 %)
18 diff
(97.8 %id)
DA314413 hippocampus .c 333 to 889 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BF573593 melanotic melanoma, high MDR, skin .c 333 to 746 1 to 414       414/415
(99 %)
3 diff
(99.3 %id)
BF978545 melanotic melanoma, high MDR, skin .c 333 to 1066 1 to 734       734/843
(87 %)
24 diff
(97.2 %id)
BG613453 embryonal carcinoma, testis .c 333 to 1067 1 to 736       736/846
(86 %)
31 diff
(96.4 %id)
BG614582 embryonal carcinoma, testis .c 333 to 1062 1 to 743       743/787
(94 %)
40 diff
(95.0 %id)
BQ924949 large cell carcinoma, lung .c 333 to 1243 1 to 911       911/911
(100 %)
5 diff
(99.5 %id)
BP298804   .c 333 to 912 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP303616   .c 333 to 913 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BF570709 melanotic melanoma, high MDR, skin .c 334 to 840 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
BF692268 melanotic melanoma, high MDR, skin .c 334 to 1071 1 to 741       741/899
(82 %)
17 diff
(98.2 %id)
BG325641 Kidney, renal cell adenocarcinoma .c 334 to 1020 1 to 687       687/934
(73 %)
8 diff
(99.2 %id)
BG504017 embryonal carcinoma, testis .c 334 to 1031 1 to 699       699/699
(100 %)
5 diff
(99.3 %id)
TI_45212711   .c 334 to 1185 94 to 956       863/958
(90 %)
30 diff
(96.9 %id)
BP297969   .c 334 to 910 1 to 577       577/580
(99 %)
2 diff
(99.7 %id)
DA979174 synovial membrane tissue from rheumatioidarthritis .c 334 to 910 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DN996680 breast cancer, Mammary gland (cancer tissue) .c 334 to 1009 1 to 676       676/676
(100 %)
9 diff
(98.7 %id)
BP360097 thalamus .c 334 to 915 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP295348   .c 335 to 916 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP295672   .c 335 to 916 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP300691   .c 335 to 910 1 to 576       576/587
(98 %)
0 diff
(100 %id)
BP306453   .c 335 to 906 1 to 572       572/572
(100 %)
0 diff
(100 %id)
BG760375 melanotic melanoma, high MDR (cell line), skin .c 336 to 886 1 to 551       551/552
(99 %)
2 diff
(99.7 %id)
BM473825 melanotic melanoma, skin .c 336 to 1287 1 to 951       951/956
(99 %)
15 diff
(98.5 %id)
EB387602 eye, optic nerve .c 338 to 1174 1 to 837       837/837
(100 %)
9 diff
(99.0 %id)
BF691659 melanotic melanoma, high MDR, skin .c 343 to 1068 1 to 716       716/771
(92 %)
18 diff
(97.7 %id)
BG767092 melanotic melanoma, high MDR (cell line), skin .c 343 to 986 1 to 643       643/643
(100 %)
2 diff
(99.7 %id)
BC014549 Bone marrow, acute myelogenous leukemia .c 345 to 1561 1 to 1217 H335R available from MGC, AAA   1217/1217
(100 %)
3 diff
(99.8 %id)
BG256311 embryonal carcinoma, cell line, testis .c 345 to 1143 1 to 801       801/876
(91 %)
28 diff
(96.9 %id)
BG281354 melanotic melanoma, skin .c 345 to 1132 1 to 786       786/787
(99 %)
5 diff
(99.4 %id)
BG325546 Kidney, renal cell adenocarcinoma .c 345 to 1066 1 to 718       718/736
(97 %)
15 diff
(98.0 %id)
BG762736 melanotic melanoma, high MDR (cell line), skin .c 345 to 1156 1 to 811       811/811
(100 %)
7 diff
(99.2 %id)
BG764365 melanotic melanoma, high MDR (cell line), skin .c 345 to 1077 1 to 742       742/912
(81 %)
27 diff
(97.1 %id)
BG769076 melanotic melanoma, high MDR (cell line), skin .c 345 to 1109 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
TI_1948122176   .c 345 to 941 207 to 804   fully sequenced,   598/598
(100 %)
0 diff
(100 %id)
TI_1948122351   .c 345 to 843 207 to 705   fully sequenced,   499/499
(100 %)
0 diff
(100 %id)
TI_1948122527   .c 345 to 843 206 to 704   fully sequenced,   499/499
(100 %)
0 diff
(100 %id)
TI_1948122693   .c 345 to 843 194 to 692   fully sequenced,   499/499
(100 %)
0 diff
(100 %id)
BG762247 melanotic melanoma, high MDR (cell line), skin .c 346 to 1180 1 to 829       829/833
(99 %)
11 diff
(98.7 %id)
BG770666 melanotic melanoma, high MDR (cell line), skin .c 346 to 1068 1 to 724       724/838
(86 %)
8 diff
(99.1 %id)
BG763461 melanotic melanoma, high MDR (cell line), skin .c 346 to 1154 1 to 801       801/969
(82 %)
13 diff
(98.7 %id)
BG764660 melanotic melanoma, high MDR (cell line), skin .c 346 to 1213 1 to 869       869/869
(100 %)
23 diff
(97.4 %id)
BG766121 melanotic melanoma, high MDR (cell line), skin .c 346 to 1152 1 to 805       805/837
(96 %)
12 diff
(98.6 %id)
BG765622 melanotic melanoma, high MDR (cell line), skin .c 346 to 1154 1 to 808       808/992
(81 %)
19 diff
(98.1 %id)
BG769966 melanotic melanoma, high MDR (cell line), skin .c 346 to 1137 1 to 790       790/791
(99 %)
11 diff
(98.7 %id)
BG769399 melanotic melanoma, high MDR (cell line), skin .c 346 to 1047 1 to 708       708/708
(100 %)
15 diff
(97.9 %id)
BG770137 melanotic melanoma, high MDR (cell line), skin .c 346 to 973 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
M94345   .c 346 to 1566 1 to 1221 H335R     1221/1221
(100 %)
3 diff
(99.8 %id)
BC000728 Placenta, choriocarcinoma .c 347 to 1563 1 to 1217 H335R available from MGC, AAA   1217/1217
(100 %)
2 diff
(99.9 %id)
BG746538 adenocarcinoma cell line, colon .c 347 to 1057 1 to 710       710/762
(93 %)
5 diff
(99.4 %id)
BG746840 adenocarcinoma cell line, colon .c 347 to 1028 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
BQ892693 melanotic melanoma, cell line, skin .c 347 to 1152 1 to 811       811/841
(96 %)
9 diff
(99.0 %id)
BU838901 melanotic melanoma, cell line, skin .c 347 to 1060 1 to 715       715/922
(77 %)
15 diff
(98.4 %id)
BQ931966 epidermoid carcinoma, cell line, lung .c 347 to 1154 1 to 810       810/886
(91 %)
5 diff
(99.5 %id)
BF664350 B-cells, primary B-cells from tonsils (cell line) .c 348 to 1124 1 to 773       773/1138
(67 %)
20 diff
(98.3 %id)
BG503302 embryonal carcinoma, testis .c 348 to 1063 1 to 715       715/718
(99 %)
9 diff
(98.8 %id)
BG763425 melanotic melanoma, high MDR (cell line), skin .c 348 to 772 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
BQ228465 melanotic melanoma, skin .c 348 to 1213 1 to 866       866/866
(100 %)
2 diff
(99.8 %id)
BQ676557 melanotic melanoma, cell line, skin .c 348 to 1061 1 to 716       716/948
(75 %)
12 diff
(98.8 %id)
BQ923740 epidermoid carcinoma, cell line, lung .c 348 to 1138 1 to 793       793/861
(92 %)
4 diff
(99.6 %id)
BM083558 embryonal carcinoma, testis .c 349 to 941 1 to 593       593/597
(99 %)
10 diff
(98.4 %id)
BG760603 melanotic melanoma, high MDR (cell line), skin .c 349 to 1228 1 to 869       874/913
(95 %)
31 diff
(96.7 %id)
BG768809 melanotic melanoma, high MDR (cell line), skin .c 350 to 1135 1 to 784       784/784
(100 %)
5 diff
(99.4 %id)
DA682465 ovary .c 350 to 920 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BG763101 melanotic melanoma, high MDR (cell line), skin .c 351 to 1184 1 to 833       833/833
(100 %)
5 diff
(99.4 %id)
BG763597 melanotic melanoma, high MDR (cell line), skin .c 351 to 1121 1 to 771       771/773
(99 %)
3 diff
(99.7 %id)
BG764437 melanotic melanoma, high MDR (cell line), skin .c 351 to 1155 1 to 803       803/852
(94 %)
7 diff
(99.2 %id)
BG768872 melanotic melanoma, high MDR (cell line), skin .c 351 to 1012 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BG761139 melanotic melanoma, high MDR (cell line), skin .c 353 to 1049 1 to 700       700/726
(96 %)
5 diff
(99.4 %id)
BG761311 melanotic melanoma, high MDR (cell line), skin .c 353 to 1125 1 to 778       778/941
(82 %)
15 diff
(98.5 %id)
BU194778 melanotic melanoma, skin .c 353 to 1123 1 to 778       778/788
(98 %)
9 diff
(98.9 %id)
BG386426 adenocarcinoma cell line, colon .c 354 to 1154 1 to 805       805/934
(86 %)
27 diff
(97.2 %id)
BQ683668 melanotic melanoma, cell line, skin .c 355 to 1282 1 to 928       928/938
(98 %)
8 diff
(99.2 %id)
BQ683793 melanotic melanoma, cell line, skin .c 355 to 1307 1 to 956       956/958
(99 %)
8 diff
(99.2 %id)
DT215971 brain .c 356 to 1013 1 to 658       658/658
(100 %)
2 diff
(99.7 %id)
DT216019 brain .c 356 to 1049 1 to 694       694/694
(100 %)
2 diff
(99.8 %id)
BG763267 melanotic melanoma, high MDR (cell line), skin .c 356 to 1063 1 to 708       708/708
(100 %)
2 diff
(99.8 %id)
BP330206 rectum .c 356 to 938 1 to 582       582/587
(99 %)
3 diff
(99.5 %id)
BE512912 adenocarcinoma cell line, colon .c 357 to 1149 1 to 793       793/865
(91 %)
35 diff
(96.0 %id)
BG422876 Kidney, renal cell adenocarcinoma .c 357 to 1071 1 to 714       714/924
(77 %)
19 diff
(98.0 %id)
BG761132 melanotic melanoma, high MDR (cell line), skin .c 357 to 1067 1 to 712       712/773
(92 %)
15 diff
(98.1 %id)
BG764165 melanotic melanoma, high MDR (cell line), skin .c 357 to 1153 1 to 797       797/797
(100 %)
11 diff
(98.7 %id)
BG766840 melanotic melanoma, high MDR (cell line), skin .c 357 to 1108 1 to 753       753/754
(99 %)
3 diff
(99.7 %id)
BG767974 melanotic melanoma, high MDR (cell line), skin .c 357 to 1071 1 to 715       715/716
(99 %)
4 diff
(99.5 %id)
BU175612 embryonal carcinoma, cell line, testis .c 357 to 1260 1 to 915       829/920
(90 %)
23 diff
(97.5 %id)
BQ437729 melanotic melanoma, skin .c 357 to 1210 1 to 859       859/863
(99 %)
11 diff
(98.8 %id)
DB224031 trachea .c 357 to 925 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
BF691321 melanotic melanoma, high MDR, skin .c 359 to 1066 1 to 706       706/905
(78 %)
14 diff
(98.5 %id)
BQ933730 large cell carcinoma, lung .c 359 to 1280 1 to 922       922/923
(99 %)
6 diff
(99.4 %id)
CX782791 human embryonic stem cells .c 360 to 1012 1 to 653   fully sequenced,   653/653
(100 %)
0 diff
(100 %id)
BF689405 melanotic melanoma, high MDR (cell line), skin .c 361 to 910 1 to 549       549/763
(71 %)
2 diff
(99.8 %id)
BF689623 melanotic melanoma, high MDR (cell line), skin .c 361 to 941 1 to 576   fully sequenced,   576/576
(100 %)
4 diff
(99.4 %id)
BF977100 melanotic melanoma, high MDR, skin .c 361 to 1069 1 to 703       703/817
(86 %)
36 diff
(95.6 %id)
BG764034 melanotic melanoma, high MDR (cell line), skin .c 361 to 1122 1 to 762       762/762
(100 %)
4 diff
(99.5 %id)
AA305951   .c 362 to 863 1 to 502       502/502
(100 %)
4 diff
(99.3 %id)
BI850340 melanotic melanoma, high MDR, skin .c 362 to 910 1 to 545       545/604
(90 %)
7 diff
(98.9 %id)
BQ420938 embryonal carcinoma, cell line, testis .c 362 to 1215 1 to 858       858/858
(100 %)
6 diff
(99.4 %id)
CB129090 Liver .c 362 to 897 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
BE391231 endometrium, adenocarcinoma cell line, uterus .c 363 to 1019 1 to 653       653/693
(94 %)
9 diff
(98.8 %id)
BG248173 adenocarcinoma cell line, colon .c 363 to 1104 1 to 737       737/878
(83 %)
14 diff
(98.5 %id)
BG248706 adenocarcinoma cell line, colon .c 363 to 1068 1 to 703       703/806
(87 %)
8 diff
(99.1 %id)
BG821469 adenocarcinoma cell line, colon .c 363 to 1132 1 to 771       771/773
(99 %)
9 diff
(98.9 %id)
BG762163 melanotic melanoma, high MDR (cell line), skin .c 364 to 1287 1 to 935       935/948
(98 %)
26 diff
(97.3 %id)
AA306606   .c 365 to 687 1 to 323       323/328
(98 %)
1 diff
(99.7 %id)
BE385589 melanotic melanoma, skin .c 365 to 1015 1 to 649       649/649
(100 %)
7 diff
(99.0 %id)
BE409429 choriocarcinoma, placenta .c 365 to 1000 1 to 634       634/641
(98 %)
11 diff
(98.3 %id)
BQ215036 embryonal carcinoma, cell line, testis .c 365 to 990 1 to 628       628/892
(70 %)
6 diff
(99.4 %id)
BE279998 choriocarcinoma, placenta .c 366 to 958 1 to 594       594/595
(99 %)
2 diff
(99.7 %id)
BE272846 Kidney, renal cell adenocarcinoma .c 367 to 736 1 to 370       370/374
(98 %)
1 diff
(99.8 %id)
AW327272 blood, T cell leukemia .c 368 to 980 1 to 616       616/616
(100 %)
5 diff
(99.2 %id)
BG762526 melanotic melanoma, high MDR (cell line), skin .c 368 to 1155 1 to 787       787/867
(90 %)
10 diff
(98.9 %id)
BG763128 melanotic melanoma, high MDR (cell line), skin .c 368 to 1154 1 to 788       788/997
(79 %)
23 diff
(97.7 %id)
BG768194 melanotic melanoma, high MDR (cell line), skin .c 368 to 1287 1 to 929       927/965
(96 %)
31 diff
(96.8 %id)
BM727033 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 369 to 1009 1 to 643       643/643
(100 %)
4 diff
(99.4 %id)
BG763238 melanotic melanoma, high MDR (cell line), skin .c 372 to 1196 2 to 838       837/861
(97 %)
25 diff
(97.1 %id)
TI_57220889   .c 372 to 1041 32 to 701       670/701
(95 %)
1 diff
(99.9 %id)
BF525939 brain, glioblastoma with EGFR amplification .c 376 to 1154 1 to 783       783/827
(94 %)
13 diff
(98.5 %id)
BG766114 melanotic melanoma, high MDR (cell line), skin .c 376 to 1278 1 to 919       919/921
(99 %)
45 diff
(95.2 %id)
CR604518 T cells (Jurkat cell line) Cot10-normalized .c 380 to 1565 1 to 1186 exact     1186/1186
(100 %)
0 diff
(100 %id)
BX361804   .c 380 to 1091 1 to 709   fully sequenced,   709/709
(100 %)
4 diff
(99.5 %id)
TI_1948076130   .c 387 to 941 131 to 685   fully sequenced,   555/685
(81 %)
6 diff
(99.2 %id)
TI_1948076311   .c 387 to 941 130 to 684   fully sequenced,   555/684
(81 %)
6 diff
(99.2 %id)
TI_1948076490   .c 387 to 941 132 to 686   fully sequenced,   555/686
(80 %)
6 diff
(99.2 %id)
TI_1948076669   .c 387 to 941 134 to 688   fully sequenced,   555/688
(80 %)
6 diff
(99.2 %id)
CB054856 brain, glioblastoma (pooled) .c 400 to 1011 3 to 614   fully sequenced,   612/614
(99 %)
6 diff
(99.1 %id)
BG760861 melanotic melanoma, high MDR (cell line), skin .c 584 to 1439 1 to 857       855/858
(99 %)
22 diff
(97.5 %id)
BG765326 melanotic melanoma, high MDR (cell line), skin .c 585 to 1447 1 to 868       869/884
(98 %)
22 diff
(97.6 %id)
TI_151754599   .c 619 to 1468 925 to 86       840/986
(85 %)
14 diff
(98.6 %id)
BG762106 melanotic melanoma, high MDR (cell line), skin .c 657 to 1555 1 to 913       913/916
(99 %)
40 diff
(95.7 %id)
BG770461 melanotic melanoma, high MDR (cell line), skin .c 670 to 1503 1 to 836       836/836
(100 %)
10 diff
(98.9 %id)
BG769299 melanotic melanoma, high MDR (cell line), skin .c 674 to 1476 1 to 814       814/888
(91 %)
22 diff
(97.6 %id)
BM042777 melanotic melanoma, cell line, skin .c 692 to 1489 799 to 5       795/799
(99 %)
18 diff
(97.8 %id)
BG767205 melanotic melanoma, high MDR (cell line), skin .c 695 to 1548 1 to 854       854/874
(97 %)
20 diff
(97.8 %id)
CN261521 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 708 to 1452 1 to 744       744/744
(100 %)
8 diff
(99.0 %id)
TI_154193515   .c 715 to 1581 51 to 914       864/1038
(83 %)
12 diff
(98.9 %id)
CF127831 Chondrosarcoma Lung Metastasis cell lines, lung .c 716 to 1456 1 to 739       739/740
(99 %)
6 diff
(99.2 %id)
TI_159710662   .c 735 to 1580 977 to 142   AAA   836/963
(86 %)
66 diff
(93.2 %id)
TI_149297886   .c 738 to 1566 917 to 94   AAA   824/955
(86 %)
16 diff
(98.4 %id)
TI_159705463   .c 743 to 1566 856 to 35   AAA   822/1002
(82 %)
5 diff
(99.6 %id)
TI_151754202   .c 747 to 1580 965 to 137   AAA   829/858
(96 %)
31 diff
(96.4 %id)
BI255453 cervical carcinoma cell line, cervix .c 757 to 1531 1 to 775       775/775
(100 %)
12 diff
(98.5 %id)
TI_151728160   .c 765 to 1475 784 to 74       711/784
(90 %)
6 diff
(99.3 %id)
BG764096 melanotic melanoma, high MDR (cell line), skin .c 776 to 1567 1 to 791       791/797
(99 %)
5 diff
(99.4 %id)
BG769420 melanotic melanoma, high MDR (cell line), skin .c 776 to 1567 1 to 797       797/806
(98 %)
18 diff
(97.8 %id)
TI_57151629   .c 785 to 1459 86 to 758       673/758
(88 %)
7 diff
(99.1 %id)
BI763682 pooled colon, kidney, stomach .c 786 to 1459 1 to 673       673/673
(100 %)
6 diff
(99.2 %id)
TI_227713238   .c 790 to 1566 836 to 64   AAA   773/970
(79 %)
10 diff
(99.0 %id)
BI765136 pooled colon, kidney, stomach .c 792 to 1647 1 to 863   tiling clone,   863/866
(99 %)
42 diff
(95.2 %id)
TI_57153030   .c 792 to 1647 34 to 896       863/899
(95 %)
47 diff
(94.8 %id)
CD743072 Alveolar Macrophage, lung .c 793 to 1566 789 to 19   AAA   771/771
(100 %)
3 diff
(99.7 %id)
BG768504 melanotic melanoma, high MDR (cell line), skin .c 804 to 1530 1 to 732       732/732
(100 %)
9 diff
(98.8 %id)
BG832235 epithelioid carcinoma cell line, Pancreas .c 805 to 1481 12 to 688       677/919
(73 %)
13 diff
(98.6 %id)
TI_149301286   .c 806 to 1566 817 to 64   AAA   754/919
(82 %)
14 diff
(98.5 %id)
TI_154127971   .c 807 to 1566 847 to 96   AAA   752/949
(79 %)
13 diff
(98.7 %id)
TI_149296177   .c 811 to 1566 839 to 90   AAA   750/921
(81 %)
8 diff
(99.2 %id)
TI_1948122352   .c 813 to 1529 813 to 96   fully sequenced,   718/813
(88 %)
1 diff
(99.9 %id)
TI_1948122528   .c 813 to 1561 809 to 59   fully sequenced,   751/809
(92 %)
1 diff
(99.9 %id)
TI_1948122694   .c 813 to 1561 810 to 61   fully sequenced,   750/810
(92 %)
1 diff
(99.9 %id)
BG397793 B-cells, primary B-cells from tonsils (cell line) .c 816 to 1566 1 to 751       751/752
(99 %)
6 diff
(99.3 %id)
BG398235 B-cells, primary B-cells from tonsils (cell line) .c 816 to 1533 1 to 719       719/719
(100 %)
10 diff
(98.7 %id)
BG765706 melanotic melanoma, high MDR (cell line), skin .c 817 to 1557 1 to 742       742/742
(100 %)
3 diff
(99.6 %id)
BU508762 leiomyosarcoma, uterus .c 832 to 1531 1 to 711       711/985
(72 %)
13 diff
(98.7 %id)
BQ027095 Chondrosarcoma, Left Pubic Bone .c 865 to 1566 717 to 19   AAA   699/699
(100 %)
5 diff
(99.3 %id)
TI_149304142   .c 866 to 1580 796 to 83   AAA   714/714
(100 %)
4 diff
(99.5 %id)
BG765134 melanotic melanoma, high MDR (cell line), skin .c 867 to 1569 1 to 704       704/704
(100 %)
8 diff
(98.9 %id)
BM794279 Ascites, stomach .c 875 to 1518 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
BF690527 melanotic melanoma, high MDR (cell line), skin .c 880 to 1535 657 to 1   fully sequenced,   657/657
(100 %)
8 diff
(98.8 %id)
TI_1948076131   .c 880 to 1440 687 to 127   fully sequenced,   561/687
(81 %)
0 diff
(100 %id)
TI_1948076312   .c 880 to 1440 688 to 128   fully sequenced,   561/688
(81 %)
0 diff
(100 %id)
TI_1948076491   .c 880 to 1440 686 to 126   fully sequenced,   561/686
(81 %)
0 diff
(100 %id)
TI_1948076670   .c 880 to 1440 687 to 127   fully sequenced,   561/687
(81 %)
1 diff
(99.9 %id)
TI_1948122177   .c 880 to 1561 741 to 58   fully sequenced,   684/741
(92 %)
1 diff
(99.9 %id)
AI686931 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 881 to 1566 687 to 1       687/688
(99 %)
22 diff
(96.9 %id)
BQ006457 Chondrosarcoma, Left Pelvis .c 887 to 1580 712 to 19   AAA   694/694
(100 %)
0 diff
(100 %id)
CA306334 Alveolar Macrophage, lung .c 887 to 1566 698 to 19   AAA   680/680
(100 %)
0 diff
(100 %id)
CD369863 Alveolar Macrophage, lung .c 887 to 1580 712 to 19   AAA   694/694
(100 %)
0 diff
(100 %id)
BM982016 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 889 to 1580 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
BU631484 cell lines, Chondrosarcoma .c 889 to 1566 696 to 19   AAA   678/678
(100 %)
1 diff
(99.9 %id)
BU626913 Alveolar Macrophage, lung .c 897 to 1586 708 to 19   tiling clone, AAA   690/690
(100 %)
1 diff
(99.9 %id)
BM990814 lung, Lung Focal Fibrosis .c 898 to 1580 701 to 19   AAA   683/683
(100 %)
1 diff
(99.9 %id)
CA306463 Alveolar Macrophage, lung .c 900 to 1580 699 to 19   AAA   681/681
(100 %)
0 diff
(100 %id)
CA306702 Alveolar Macrophage, lung .c 906 to 1580 693 to 19   AAA   675/675
(100 %)
2 diff
(99.8 %id)
BF690354 melanotic melanoma, high MDR (cell line), skin .c 908 to 1517 616 to 5       612/883
(69 %)
5 diff
(99.5 %id)
BQ044970 Knee, Osteoarthritic Cartilage .c 908 to 1580 691 to 19   AAA   673/673
(100 %)
2 diff
(99.8 %id)
AW104148 ovary, tumor, 5 pooled (see description) .c 909 to 1581 684 to 9       676/727
(92 %)
18 diff
(97.6 %id)
AW103434 ovary, tumor, 5 pooled (see description) .c 912 to 1566 654 to 1       654/661
(98 %)
16 diff
(97.6 %id)
AW009696 colon .c 917 to 1567 651 to 1       651/651
(100 %)
3 diff
(99.6 %id)
BM982886 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 918 to 1566 667 to 19   AAA   649/649
(100 %)
1 diff
(99.9 %id)
CA423050 cell lines, Chondrosarcoma .c 919 to 1580 680 to 19   AAA   662/662
(100 %)
3 diff
(99.6 %id)
BU630487 cell lines, Chondrosarcoma .c 919 to 1580 680 to 19   AAA   662/662
(100 %)
1 diff
(99.9 %id)
AI564501 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 920 to 1561 666 to 24   AAA   643/714
(90 %)
18 diff
(97.5 %id)
AI680983 carcinoid, lung .c 923 to 1567 646 to 2       645/649
(99 %)
18 diff
(97.3 %id)
AI830964 lymph node, lymphoma, follicular mixed small and largecell .c 923 to 1563 647 to 7       641/689
(93 %)
11 diff
(98.5 %id)
CA307495 Alveolar Macrophage, lung .c 926 to 1580 673 to 19   AAA   655/655
(100 %)
6 diff
(99.1 %id)
AA627656 colon, colon tumor RER+ .c 932 to 1566 640 to 11       630/640
(98 %)
15 diff
(97.7 %id)
AA554556 breast .c 947 to 1569 625 to 1       625/633
(98 %)
35 diff
(94.5 %id)
BE675228 B-cell, chronic lymphotic leukemia .c 947 to 1580 653 to 20   AAA   634/634
(100 %)
13 diff
(98.0 %id)
AW950880   .c 948 to 1566 1 to 619   AAA   619/619
(100 %)
5 diff
(99.2 %id)
AA993858   .c 948 to 1567 623 to 7       617/625
(98 %)
16 diff
(97.5 %id)
BQ002073 Chondrosarcoma, Left Pubic Bone .c 950 to 1583 652 to 19   AAA   634/634
(100 %)
1 diff
(99.9 %id)
BU626792 Alveolar Macrophage, lung .c 951 to 1582 650 to 19   AAA   632/632
(100 %)
3 diff
(99.6 %id)
CD368440 Alveolar Macrophage, lung .c 951 to 1580 648 to 19   AAA   630/630
(100 %)
1 diff
(99.9 %id)
CD367562 Alveolar Macrophage, lung .c 952 to 1566 633 to 19   AAA   615/615
(100 %)
4 diff
(99.4 %id)
BQ021221 lung, Metastatic Chondrosarcoma .c 953 to 1566 632 to 19   AAA   614/626
(98 %)
1 diff
(99.9 %id)
AI338422   .c 957 to 1571 634 to 19   AAA   616/617
(99 %)
11 diff
(98.3 %id)
AW006174 anaplastic oligodendroglioma, brain .c 957 to 1583 627 to 1       627/628
(99 %)
3 diff
(99.6 %id)
AW419082 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 957 to 1580 625 to 1       625/628
(99 %)
4 diff
(99.4 %id)
CA748649 Alveolar Macrophage, lung .c 957 to 1580 639 to 16   AAA   624/624
(100 %)
2 diff
(99.7 %id)
BM310317 insulinoma, Pancreas .c 959 to 1566 630 to 22   AAA   609/609
(100 %)
6 diff
(99.1 %id)
BG760417 melanotic melanoma, high MDR (cell line), skin .c 969 to 1532 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BM793764 Ascites, stomach .c 971 to 1567 1 to 597       597/604
(98 %)
2 diff
(99.7 %id)
CA421855 Bone, Enchondroma cell line .c 973 to 1580 626 to 19   AAA   608/608
(100 %)
0 diff
(100 %id)
AI469240 colon, moderately-differentiated adenocarcinoma .c 974 to 1567 593 to 1       593/601
(98 %)
13 diff
(97.9 %id)
BU684192 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 980 to 1566 605 to 19   AAA   587/587
(100 %)
0 diff
(100 %id)
CB054855 brain, glioblastoma (pooled) .c 981 to 1586 638 to 33   fully sequenced, AAA   606/606
(100 %)
8 diff
(98.7 %id)
CX782713 human embryonic stem cells .c 982 to 1580 624 to 26   fully sequenced, AAA   599/599
(100 %)
4 diff
(99.4 %id)
BM979917 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 982 to 1566 603 to 19   AAA   585/585
(100 %)
1 diff
(99.9 %id)
BU629385 cell lines, Chondrosarcoma .c 982 to 1566 603 to 19   AAA   585/585
(100 %)
1 diff
(99.9 %id)
AA522877 lung, lung tumor .c 990 to 1563 576 to 3       574/577
(99 %)
2 diff
(99.7 %id)
BM993349 lung, Metastatic Chondrosarcoma .c 990 to 1566 596 to 20   AAA   577/577
(100 %)
1 diff
(99.9 %id)
BU629954 cell lines, Chondrosarcoma .c 990 to 1566 595 to 19   AAA   577/577
(100 %)
2 diff
(99.7 %id)
AA121128 colon, tumor .c 999 to 1246 1 to 249   fully sequenced,   249/249
(100 %)
3 diff
(98.8 %id)
AW516652 cervix, tumor .c 1014 to 1581 573 to 5       569/574
(99 %)
11 diff
(98.1 %id)
CA428442 cell lines, Chondrosarcoma .c 1018 to 1586 587 to 19   AAA   569/569
(100 %)
1 diff
(99.9 %id)
AA779573   .c 1019 to 1567 555 to 8       548/555
(98 %)
4 diff
(99.3 %id)
AA743027 germinal center B cell .c 1021 to 1581 568 to 9       560/606
(92 %)
11 diff
(98.2 %id)
BX352247   .c 1030 to 1565 537 to 1   fully sequenced,   537/537
(100 %)
5 diff
(99.1 %id)
BU531827 mixed (pool of 40 RNAs) .c 1032 to 1586 1 to 557       557/586
(95 %)
9 diff
(98.5 %id)
BQ229069 melanotic melanoma, skin .c 1037 to 1566 1 to 530   AAA   530/530
(100 %)
1 diff
(99.9 %id)
BQ017769 Chondrosarcoma, Left Pubic Bone .c 1038 to 1566 547 to 19   AAA   529/529
(100 %)
2 diff
(99.7 %id)
AA614745 breast .c 1046 to 1581 539 to 4       536/539
(99 %)
1 diff
(99.9 %id)
AA772612 parathyroid gland, parathyroid tumor .c 1058 to 1581 527 to 6       522/527
(99 %)
5 diff
(99.1 %id)
AA564744 germ cell tumor .c 1058 to 1563 508 to 3       506/514
(98 %)
1 diff
(99.9 %id)
AW513322 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1058 to 1580 524 to 1       524/596
(87 %)
3 diff
(99.5 %id)
TI_149289159   .c 1059 to 1561 600 to 98   AAA   503/652
(77 %)
4 diff
(99.4 %id)
AW304111 lung, two pooled squamous cell carcinomas .c 1060 to 1561 511 to 12   AAA   500/508
(98 %)
18 diff
(96.5 %id)
AA657985 invasive tumor (cell line), Prostate .c 1065 to 1568 529 to 27   AAA   503/504
(99 %)
4 diff
(99.3 %id)
AW973699   .c 1067 to 1569 504 to 1     Submitted on the opposite strand 504/504
(100 %)
19 diff
(96.3 %id)
BP392398 pancreatic islet .c 1067 to 1561 1 to 495     Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
BI962606 Islets of Langerhans, Pancreas .c 1071 to 1580 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
CD369104 Alveolar Macrophage, lung .c 1071 to 1566 514 to 19   AAA   496/511
(97 %)
0 diff
(100 %id)
CD369112 Alveolar Macrophage, lung .c 1071 to 1566 514 to 19   AAA   496/505
(98 %)
0 diff
(100 %id)
AW169771 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1083 to 1581 500 to 3       498/502
(99 %)
7 diff
(98.7 %id)
BQ015618 placenta .c 1083 to 1561 496 to 18   AAA   479/479
(100 %)
3 diff
(99.4 %id)
BQ013641 placenta .c 1083 to 1561 496 to 18   AAA   479/479
(100 %)
3 diff
(99.4 %id)
BM970752 lung .c 1084 to 1561 496 to 19   AAA   478/478
(100 %)
2 diff
(99.6 %id)
CA424595 cell lines, Chondrosarcoma .c 1084 to 1566 501 to 19   AAA   483/483
(100 %)
1 diff
(99.8 %id)
BP386194 pancreatic islet .c 1087 to 1578 1 to 492     Submitted on the opposite strand 492/498
(98 %)
1 diff
(99.8 %id)
BP384338 pancreatic islet .c 1088 to 1581 1 to 494     Submitted on the opposite strand 494/498
(99 %)
1 diff
(99.8 %id)
AA552120 colon, tumor .c 1088 to 1567 482 to 3       480/482
(99 %)
1 diff
(99.8 %id)
AA580117 breast .c 1088 to 1565 478 to 1       478/478
(100 %)
2 diff
(99.6 %id)
AA922942 adenocarcinoma, colon .c 1088 to 1567 481 to 2       480/481
(99 %)
3 diff
(99.4 %id)
AA858092 adenocarcinoma, colon .c 1091 to 1566 475 to 1       475/475
(100 %)
3 diff
(99.4 %id)
AA626035   .c 1097 to 1571 474 to 1       474/474
(100 %)
4 diff
(99.2 %id)
AI820019 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1097 to 1568 483 to 12   AAA   472/472
(100 %)
9 diff
(98.1 %id)
BG164096 hypernephroma, cell line, Kidney .c 1102 to 1566 1 to 464   AAA   464/464
(100 %)
4 diff
(99.2 %id)
AI160220 brain, glioblastoma (pooled) .c 1109 to 1581 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
BQ356148 head_neck .c 1114 to 1487 375 to 4       372/375
(99 %)
2 diff
(99.5 %id)
BP389462 pancreatic islet .c 1120 to 1567 1 to 448     Submitted on the opposite strand 448/451
(99 %)
4 diff
(99.2 %id)
BE548496 cervical carcinoma cell line, cervix .c 1122 to 1566 1 to 446   AAA   446/446
(100 %)
2 diff
(99.6 %id)
AI934782 anaplastic oligodendroglioma, brain .c 1130 to 1580 463 to 13   AAA   451/451
(100 %)
9 diff
(98.1 %id)
BF063410 colon, colon tumor, RER+ .c 1131 to 1560 432 to 3       430/432
(99 %)
0 diff
(100 %id)
AI538727 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1135 to 1581 447 to 1       447/449
(99 %)
7 diff
(98.5 %id)
AA541658 normal prostate, Prostate .c 1138 to 1566 428 to 1       428/428
(100 %)
6 diff
(98.6 %id)
AI565547 anaplastic oligodendroglioma, brain .c 1140 to 1562 423 to 1       423/424
(99 %)
3 diff
(99.3 %id)
DB561022 hypothalamus .c 1169 to 1580 1 to 412     Submitted on the opposite strand 412/412
(100 %)
3 diff
(99.3 %id)
AI367619 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1171 to 1580 409 to 1       409/409
(100 %)
2 diff
(99.6 %id)
AW793313 uterus .c 1172 to 1462 293 to 4       290/293
(98 %)
0 diff
(100 %id)
AI767434 Kidney .c 1172 to 1567 401 to 6       396/401
(98 %)
0 diff
(100 %id)
AI420886 Prostate .c 1175 to 1566 409 to 18   AAA   392/392
(100 %)
0 diff
(100 %id)
BI258109 cervical carcinoma cell line, cervix .c 1177 to 1554 1 to 378       378/451
(83 %)
3 diff
(99.4 %id)
AA764755 germinal center B cell .c 1183 to 1580 409 to 14   AAA   396/396
(100 %)
4 diff
(99.0 %id)
AI500534 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1184 to 1567 390 to 8       383/390
(98 %)
4 diff
(99.0 %id)
BF686500 leiomyosarcoma cell line, uterus .c 1189 to 1566 1 to 376   AAA   376/376
(100 %)
4 diff
(99.0 %id)
AI681713 carcinoid, lung .c 1191 to 1566 375 to 1       375/375
(100 %)
3 diff
(99.2 %id)
BE219967 carcinoid, lung .c 1191 to 1581 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AA486942 lung .c 1193 to 1521 1 to 328   fully sequenced,   328/328
(100 %)
3 diff
(99.1 %id)
AA935695 carcinoid, lung .c 1195 to 1566 394 to 23   AAA   372/374
(99 %)
5 diff
(98.7 %id)
AI470307 pooled .c 1202 to 1566 376 to 11   AAA   366/369
(99 %)
13 diff
(96.5 %id)
AW612818 carcinoid, lung .c 1203 to 1581 381 to 1       381/386
(98 %)
11 diff
(97.2 %id)
AA577037 colon, colon tumor RER+ .c 1205 to 1567 364 to 2       363/364
(99 %)
0 diff
(100 %id)
AI261773 Kidney .c 1205 to 1563 373 to 15   AAA   359/359
(100 %)
2 diff
(99.5 %id)
AA732156 germinal center B cell .c 1212 to 1566 408 to 53   AAA   356/356
(100 %)
1 diff
(99.8 %id)
BP305883   .c 1215 to 1564 1 to 350       350/433
(80 %)
1 diff
(99.8 %id)
AA121148 colon, tumor .c 1216 to 1581 369 to 3   fully sequenced,   367/369
(99 %)
0 diff
(100 %id)
BU580005 insulinoma, Pancreas .c 1217 to 1580 1 to 364       364/364
(100 %)
5 diff
(98.7 %id)
BF692550 melanotic melanoma, high MDR, skin .c 1222 to 1580 1 to 358   AAA   358/358
(100 %)
4 diff
(98.9 %id)
AW005720 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1223 to 1566 360 to 18   AAA   343/343
(100 %)
10 diff
(97.1 %id)
AW474835 lymph node, lymphoma, follicular mixed small and largecell .c 1235 to 1561 331 to 5       327/331
(98 %)
0 diff
(100 %id)
H49082 liver and spleen .c 1247 to 1436 190 to 1       190/190
(100 %)
0 diff
(100 %id)
BM788864 stomach .c 1248 to 1580 1 to 333       333/346
(96 %)
1 diff
(99.8 %id)
AI628473 Kidney .c 1253 to 1569 323 to 7       317/323
(98 %)
0 diff
(100 %id)
BP390208 pancreatic islet .c 1262 to 1580 1 to 319     Submitted on the opposite strand 319/319
(100 %)
0 diff
(100 %id)
AA470737 colon .c 1264 to 1567 305 to 3       303/305
(99 %)
1 diff
(99.7 %id)
BU171611 melanotic melanoma, skin .c 1268 to 1566 1 to 299   AAA   299/299
(100 %)
1 diff
(99.7 %id)
AI652250 pooled germ cell tumors .c 1281 to 1566 286 to 1       286/286
(100 %)
0 diff
(100 %id)
BE673284 Prostate .c 1281 to 1567 290 to 4       287/290
(98 %)
0 diff
(100 %id)
BM739315 Ascites, stomach .c 1285 to 1566 1 to 283   AAA   283/283
(100 %)
2 diff
(99.3 %id)
AI332465 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1288 to 1580 293 to 1       293/293
(100 %)
3 diff
(99.0 %id)
AI915065 ovary, tumor, 5 pooled (see description) .c 1294 to 1567 276 to 3       274/276
(99 %)
0 diff
(100 %id)
AI971332 Prostate .c 1294 to 1560 267 to 1       267/267
(100 %)
0 diff
(100 %id)
BX400911   .c 1309 to 1564 1 to 256       256/256
(100 %)
4 diff
(98.5 %id)
AI420057 Prostate .c 1314 to 1581 272 to 5       268/272
(98 %)
0 diff
(100 %id)
BE856179 Prostate .c 1320 to 1563 256 to 13   AAA   244/244
(100 %)
1 diff
(99.6 %id)
AI631581 pooled germ cell tumors .c 1354 to 1562 230 to 22   AAA   209/209
(100 %)
2 diff
(99.1 %id)
DW443373 Liver .c 1357 to 1579 7 to 230       224/230
(97 %)
8 diff
(96.6 %id)
AA486766 lung .c 1373 to 1528 156 to 1   fully sequenced,   156/156
(100 %)
1 diff
(99.4 %id)
AI380770 B-cell, chronic lymphotic leukemia .c 1373 to 1566 229 to 36   AAA   194/195
(99 %)
4 diff
(98.0 %id)
BF221769 Prostate .c 1380 to 1580 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AA770317   .c 1429 to 1543 1 to 115     Submitted on the opposite strand 115/115
(100 %)
0 diff
(100 %id)
F17865 pectoral muscle (after mastectomy) .c 1429 to 1567 1 to 139       139/139
(100 %)
6 diff
(95.7 %id)
CB135923 Liver .d 1 to 556 1 to 556   tiling clone,   556/556
(100 %)
1 diff
(99.9 %id)
BI223482 cervical carcinoma cell line, cervix .d 33 to 832 1 to 794       794/794
(100 %)
9 diff
(98.9 %id)
BU500981 eye, normal pigmented retinal epithelium .d 33 to 845 1 to 814   tiling clone,   814/890
(91 %)
8 diff
(99.2 %id)
BE538154 cervix .d 36 to 660 1 to 634       634/1000
(63 %)
19 diff
(98.1 %id)
TI_149298460   .d 507 to 1336 914 to 86   tiling clone, AAA   829/832
(99 %)
14 diff
(98.4 %id)
BM983194 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 886 to 1336 469 to 19   AAA   451/451
(100 %)
0 diff
(100 %id)
BF056115 pooled .d 1335 to 1820 491 to 5   tiling clone,   487/491
(99 %)
0 diff
(100 %id)
AU143607   .e 1 to 834 2 to 833   tiling clone, capped   832/832
(100 %)
20 diff
(97.6 %id)
BU569493 testis .e 61 to 803 1 to 752       752/805
(93 %)
13 diff
(98.4 %id)
BG823748 adenocarcinoma cell line, colon .e 161 to 773 1 to 612       612/612
(100 %)
5 diff
(99.2 %id)
BI758296 brain .e 164 to 825 9 to 670       662/670
(98 %)
7 diff
(99.0 %id)
BE744514 adenocarcinoma cell line, ovary .e 165 to 852 1 to 686       686/950
(72 %)
9 diff
(99.1 %id)
ES314168 occipital scalp hair, skin .e 166 to 321 3 to 157       157/157
(100 %)
1 diff
(99.4 %id)
BE386057 melanotic melanoma, skin .e 166 to 797 6 to 637       637/691
(92 %)
3 diff
(99.6 %id)
AL047290 uterus .e 168 to 694 1 to 527       527/536
(98 %)
0 diff
(100 %id)
BI088318 cervix .e 168 to 844 1 to 676   tiling clone,   676/676
(100 %)
1 diff
(99.9 %id)
BE894462 melanotic melanoma, skin .e 169 to 784 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
CB160245 Liver .e 169 to 663 1 to 495       495/495
(100 %)
0 diff
(100 %id)
CV025740 mixed .e 179 to 586 1 to 408       408/408
(100 %)
0 diff
(100 %id)
CV027988 mixed .e 179 to 726 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BF683223 leiomyosarcoma cell line, uterus .e 181 to 842 1 to 672       670/1069
(62 %)
23 diff
(97.9 %id)
DA778406 brain .e 182 to 743 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BG762153 melanotic melanoma, high MDR (cell line), skin .e 196 to 843 1 to 667       612/822
(74 %)
32 diff
(96.2 %id)
BG765189 melanotic melanoma, high MDR (cell line), skin .e 196 to 852 1 to 655   tiling clone,   655/708
(92 %)
11 diff
(98.5 %id)
BG768516 melanotic melanoma, high MDR (cell line), skin .e 206 to 852 1 to 651       651/652
(99 %)
15 diff
(97.7 %id)
BE407724 choriocarcinoma, placenta .e 219 to 757 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BE537062 cervix .e 228 to 852 1 to 626       626/819
(76 %)
15 diff
(98.2 %id)
EL954196 eyeball .e 238 to 780 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
TI_57181469   .e 249 to 852 61 to 674       614/819
(74 %)
22 diff
(97.4 %id)
BI768808 pooled lung and spleen .e 253 to 852 1 to 610       610/755
(80 %)
17 diff
(97.8 %id)
BM717623 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .e 321 to 818 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BF908581 uterus_tumor .e 369 to 651 286 to 3     Submitted on the opposite strand 284/286
(99 %)
0 diff
(100 %id)
BF773498 epid_tumor .e 461 to 791 350 to 19     Submitted on the opposite strand 332/350
(94 %)
0 diff
(100 %id)
BF758194 colon .e 476 to 846 369 to 2     Submitted on the opposite strand 368/369
(99 %)
12 diff
(96.8 %id)
AW798318 uterus .e 504 to 729 226 to 1       226/226
(100 %)
2 diff
(99.2 %id)
EH341104   .e 517 to 590 1 to 74       74/74
(100 %)
0 diff
(100 %id)
FN152404 breast carcinoma .e 564 to 669 102 to 1     Submitted on the opposite strand 102/102
(100 %)
5 diff
(95.1 %id)
BI035331 nervous_normal .e 585 to 717 136 to 3       134/150
(89 %)
1 diff
(99.4 %id)
BF380309 uterus_tumor .e 586 to 775 189 to 1       189/189
(100 %)
1 diff
(99.5 %id)
CV355295 bocio_tumor .e 695 to 846 1 to 156       156/157
(99 %)
11 diff
(93.0 %id)
DB384788   .e 1062 to 1531 471 to 1   tiling clone,   471/577
(81 %)
13 diff
(97.8 %id)
BM723225 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1 to 598 9 to 606       606/606
(100 %)
1 diff
(99.9 %id)
AK225374 Kidney .f 1 to 1189 6 to 1194 H320R tiling clone, AAA   1194/1194
(100 %)
1 diff
(100.0 %id)
AK225378 Kidney .f 1 to 1189 6 to 1194 H320R AAA   1194/1194
(100 %)
1 diff
(100.0 %id)
BM682447 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 684 to 1189 524 to 19   tiling clone, AAA   509/509
(100 %)
0 diff
(100 %id)
BG769479 melanotic melanoma, high MDR (cell line), skin .g 1 to 715 1 to 715   tiling clone,   715/715
(100 %)
5 diff
(99.4 %id)
AA617814 lung, lung tumor .g 610 to 1165 569 to 15   tiling clone, AAA   555/555
(100 %)
4 diff
(99.3 %id)
CB130011 Liver .h 1 to 554 1 to 554   tiling clone,   554/554
(100 %)
2 diff
(99.7 %id)
BQ007563 Chondrosarcoma, Left Pubic Bone .h 412 to 1162 769 to 19   tiling clone, AAA   751/751
(100 %)
1 diff
(99.9 %id)
BE897282 melanotic melanoma, skin .i 1 to 754 1 to 778   tiling clone,   611/852
(71 %)
30 diff
(96.5 %id)
CA307805 Alveolar Macrophage, lung .i 462 to 1185 741 to 19   tiling clone, AAA   723/723
(100 %)
1 diff
(99.9 %id)
BM824884 Ascites, stomach .i 520 to 1125 1 to 606   tiling clone,   606/606
(100 %)
0 diff
(100 %id)
FN057418 breast carcinoma .i 916 to 979 1 to 64       64/65
(98 %)
2 diff
(97.0 %id)
BU527579 epidermoid carcinoma, cell line, lung .j 1 to 393 4 to 398   tiling clone,   398/891
(44 %)
3 diff
(99.7 %id)
BG762114 melanotic melanoma, high MDR (cell line), skin .j 40 to 955 1 to 913 A76G C77L A78C V79R L80A ... tiling clone,   913/919
(99 %)
33 diff
(96.5 %id)
BG763122 melanotic melanoma, high MDR (cell line), skin .k 1 to 887 5 to 887   tiling clone,   887/929
(95 %)
24 diff
(97.5 %id)
BG764427 melanotic melanoma, high MDR (cell line), skin .k 418 to 1185 1 to 767   tiling clone,   767/767
(100 %)
3 diff
(99.7 %id)
AW384764 head_neck .k 954 to 1136 17 to 199       183/213
(85 %)
10 diff
(95.4 %id)
BU172582 melanotic melanoma, skin .l 1 to 856 2 to 857 K266E tiling clone,   857/857
(100 %)
2 diff
(99.8 %id)
BG770347 melanotic melanoma, high MDR (cell line), skin .m 1 to 711 1 to 719   tiling clone,   719/835
(86 %)
14 diff
(98.4 %id)
BG769622 melanotic melanoma, high MDR (cell line), skin .m 1 to 833 1 to 844 K143N K145E K146E N147E I148H ... tiling clone,   844/1063
(79 %)
27 diff
(97.5 %id)
BE880214 large cell carcinoma, undifferentiated, lung .n 1 to 735 1 to 725 G40A V41S F42S F43S S44R ... tiling clone,   725/934
(77 %)
20 diff
(97.9 %id)
BF248409 melanotic melanoma, high MDR, skin .o 1 to 650 1 to 650   tiling clone,   650/879
(73 %)
38 diff
(95.7 %id)
BG767006 melanotic melanoma, high MDR (cell line), skin .o 48 to 763 1 to 716 exact tiling clone,   716/716
(100 %)
1 diff
(99.9 %id)
CN261518 embryonic stem cells, DMSO-treated H9 cellline .p 1 to 486 1 to 486 E12A H148R tiling clone,   486/486
(100 %)
2 diff
(99.6 %id)
BI825089 pooled brain, lung, testis .q 1 to 733 3 to 742 S2I P49L H51T C52A S53L ... tiling clone,   742/777
(95 %)
26 diff
(96.7 %id)
TI_57202607   .q 1 to 733 3 to 742 S2I P49L H51T C52A S53L ...     742/777
(95 %)
26 diff
(96.7 %id)
BM194066 leukopheresis .q 285 to 467 1 to 184   tiling clone,   184/184
(100 %)
1 diff
(99.5 %id)
48 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI